Single photon emission computed tomography of technetium-99m tetrofosmin myocardial perfusion imaging in patients with systemic lupus erythematosus - A preliminary report

Japanese Heart Journal

Volumn 44, Issue 1, 2003, Pages 83-89

  Lin, Jen Jhy ^a   Hsu, Hsiu Bao ^a   Sun, Shung Shung ^a   Wang, Jhi Joung ^b   Ho, Shung Tai ^c   Kao, Chia Hung ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Single photon emission computed tomography; Systemic lupus erythematosus; Technetium 99m tetrofosmin

Indexed keywords

DIPYRIDAMOLE; TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART MUSCLE PERFUSION; HEART MUSCLE RELAXATION; HEART STRESS; HUMAN; MYOCARDIAL DISEASE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; RADIOCARDIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT DEPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; HEART DISEASE; MIDDLE AGED; SCINTISCANNING;

ADULT; FEMALE; HEART DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0037264581     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.44.83     Document Type: Article

References (14)

1. Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987; 17: 126-41.
2. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1971; 50: 85-95.
3. Schillaci O, Lagana B, Danieli R, et al. Technetium-99m sestamibi single-photon emission tomography detects subclinical myocardial perfusion abnormalities in patients with systemic lupus erythematosus. Eur J Nucl Med 1999; 26: 713-7.
4. Hosenpud JD, Montanaro A, Hart MV, et al. Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. Am J Med 1984; 77: 286-92.
5. Higley B, Smith FW, Smith T, et al. Technetium-99m-1, 2-bis (bis (2-ethoxyethyl) phosphino) ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993; 34: 30-8.
6. Kelly JD, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993; 34: 222-7.
7. Flamen P, Bossuyt A. Franken PR. Technetium-99m-tetrofosmin in dipyridamole- stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestaimbi. J Nucl Med 1995; 36: 2009-15.
8. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1985; 110: 1257-65.
9. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med 1985; 55: 87-98.
10. Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL. Systemic lupus erythematosus-survival patterns. Experience with 609 patients. JAMA 1981; 245: 934-8.
11. Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheumatol 1987; 14: 223-6.
12. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992; 93: 513-9.
13. Shome GP, Sakauchi M, Yamane Y, Takemura H, Kashiwagi H. Ischemic heart disease in systemic lupus erythematosus. A retrospective study of 65 patients treated with prednisolone. Jpn J Med 1989; 28: 599-603.
14. Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valind S. Cardiovascular disease in systemic lupus erythematosus - a study of 75 patients from a defined population. Medicine 1992; 71: 216-23.